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Abstract
Several diterpenoids isolated from terrestrial and marine environments have been identified as important anti-
inflammatory agents. Although considerable progress has been made in the area of anti-inflammatory treatment, the
search for more effective and safer compounds is a very active field of research. In this study we investigated the
anti-inflammatory effects of a known pseudopterane diterpene (referred here as compound 1) isolated from the
octocoral Pseudopterogorgia acerosa on the tumor necrosis factor- alpha (TNF-α) and TLRs- induced response in
macrophages. Compound 1 inhibited the expression and secretion of the inflammatory mediators TNF-α, interleukin
(IL)-6, IL-1β, nitric oxide (NO), interferon gamma-induced protein 10 (IP-10), ciclooxygenase (COX)-2, inducible nitric
oxide synthase (iNOS) and monocyte chemoattractant protein-1 (MCP-1) induced by LPS in primary murine
macrophages. This effect was associated with the inhibition of IκBα degradation and subsequent activation of NFκB.
Compound 1 also inhibited the expression of the co-stimulatory molecules CD80 and CD86, which is a hallmark of
macrophage activation and consequent initiation of an adaptive immune response. The anti-inflammatory effect was
not exclusive to LPS because compound 1 also inhibited the response of macrophages to TNF-α and TLR2 and
TLR3 ligands. Taken together, these results indicate that compound 1 is an anti-inflammatory molecule, which
modulates a variety of processes occurring in macrophage activation.
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Introduction
Inflammation is a host response triggered by exogenous
stimuli, such as infections, or by stimuli from endogenous
sterile injuries. It is characterized by the recruitment and
accumulation of immune cells in injured sites and by the
production of soluble mediators including reactive oxygen and
nitrogen species, chemokines, lipid mediators and cytokines.
These mediators are essential for controlling the inflammation
and tissue repair, but may also exacerbate tissue damage. The
inflammatory response is initiated by cellular sensing of either
Pathogen-Associates Molecular Patterns (PAMPs) or Damage-
Associated Molecular Patterns (DAMPs) through Pattern
Recognition Receptors (PRR), such as Toll-Like Receptors
(TLRs) and NOD-Like Receptors (NLRs), which trigger specific
signaling pathways [1].
Macrophages are one of the most important cells implicated
both in the resolution and exacerbation of inflammation,
depending on the stimuli and the pattern of the elicited immune
response. Activation of macrophages by PRRs or by cytokine
receptors, such as TNF-α and IL-1β receptors (TNFR and IL1R
respectively) leads to the production of inflammatory mediators
such as NO, TNF-α, IL-1β, IL-6 and COX-2. Macrophage-
derived NO is produced by iNOS and may be beneficial due to
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its immunomodulatory, anti-tumoral and anti-pathogenic
effects. However, high and sustained levels of NO are
detrimental to the host and are involved in the pathogenesis of
several diseases [2]. Inflammatory conditions are also
associated with high levels of TNF-α and IL-1β, which have an
autocrine and paracrine effect on immune cells, potentiating
the inflammatory response.
Intracellular signaling pathways triggered by PRRs in
different cell types, including macrophages, culminate in the
activation and nuclear translocation of NFκB, which induces the
expression of most of the mediators mentioned above [3,4].
NFκB activation also regulates the transcription of several
genes implicated in apoptosis, proliferation, cellular adhesion,
stress response and tissue remodeling [5]. Due to its central
role in the inflammatory response NFκB is involved in many
human pathological conditions, including acute and chronic
inflammation, and thus constitutes a suitable target for the
development of new anti-inflammatory drugs.
The NFκB family consists of five proteins (RelA/p65, cRel,
RelB, p50, p52) that form homo- and heterodimers depending
on what genes need to be regulated. Among these, p65:p50 is
the major complex formed after cellular activation by microbial
products and pro-inflammatory cytokines [6]. NFκB activation is
controlled by the IKK complex, which induces the
phosphorylation and degradation of IκB inhibitor proteins,
allowing the nuclear translocation of these transcription factors
[7].
Most drugs used today for the treatment of disease are
derived from natural products [8]. Studies in terrestrial
organisms have been extended to marine organisms, which
have enormous potential as a source of novel active
compounds [9-12]. Among marine organisms, gorgonian
octocorals are a well-known source of natural bioactive
products. A group of compounds frequently found in octocorals
are the diterpenes, which possess a wide range of biological
activities including antibacterial, antiviral, antifungal, antitumor,
anti-inflammatory and antiprotozoal properties [13,14]. Some
coral diterpenes have been identified as modulators of NFκB
signaling pathways [15-17].
An interesting group of diterpenes restricted to the marine
environment are the pseudopteranes: a family composed of
approximately 30 members. Despite their ubiquity, the
biological properties of the majority of these diterpenes have
not been extensively explored [18]. Two of these compounds,
the pseudopterolide and the kallolide A, have been reported to
reduce the inflammatory response in a PMA-induced topical
inflammation assay [19]; however, the mechanisms involved in
this effect were not described.
We investigated the anti-inflammatory activity of a
pseudopterane diterpene (compound 1) (Figure 1), isolated
from the octocoral Pseudopterogorgia acerosa collected in
Bocas del Toro, Panama. Compound 1 was previously
described as a methanol adduct of the diterpene
pseudopterolide [20] as a consequence of the storage of the
coral specimens in methanol. Another research group later
isolated compound 1 in the absence of methanol [21]
suggesting that this metabolite is a natural product produced by
P.acerosa. We observed that compound 1 has a potent anti-
inflammatory activity. Compound 1 inhibited the expression and
secretion of several inflammatory mediators including TNF-α,
IL-6, IL-1β, NO, IP-10, COX2 and MCP-1 induced by LPS in
primary murine macrophages cultures. The anti-inflammatory
effect observed was due to the inhibition of IκBα degradation
and subsequent suppression of p50 and p65 activation.
Compound 1 also inhibited the secretion of proinflammatory
cytokines induced by TNF-α and by TLR2 and TLR3 ligands,
and reduced the expression of co-stimulatory molecules (CD80
and CD86) induced by LPS. We also compared the anti-
inflammatory activity of compound 1 with that of
isogorgiacerodiol (Figure S1) isolated from the same coral
preparation and previously described by Tinto et al. in 1991
[21]. We demonstrated that compound 1 has a higher anti-
inflammatory activity than isogorgiacerodiol. These results
indicate that compound 1 is a potential molecule for the
development of new anti-inflammatory drugs.
Materials and Methods
Mice
Female and male C57BL/6 mice, 8 weeks of age, were
obtained from INDICASAT’s mice facility. Mice were purchased
from Harlan Laboratory S.A. de C.V. and stored at INDICASAT.
The animals were kept at a constant temperature (25 °C) with
free access to food and water in a room with a 12 hours (h)
light/dark cycle.
Ethics Statement
All experiments were performed in strict accordance with
guidelines from the Institutional Animal Welfare Committee and
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was also approved
by the Institutional Animal Care and Use Committee of
INDICASAT-AIP.
Reagents
LPS 0111:B4 from E. coli, synthetic bacterial lipopeptide
(Pam3CysSerLys4), Poly I:C, were obtained from InvivoGen
(San Diego, CA). Recombinant mouse TNF-α was from R&D
Systems, Inc. (Minneapolis, MN). RPMI medium and fetal
bovine serums (FBS) for macrophage culture were obtained
from Gibco (Grand Island, NY). DMSO was obtained from
Sigma-Aldrich (St. Louis, MO).
Biological material collection and identification
The octocoral Pseudopterogorgia acerosa (Order
Gorgonacea, Family Gorgonidae) was collected by hand using
SCUBA at 4.5 m depth in Bastimentos National Park, located in
the Caribbean off the coast of Bocas del Toro, Panama in
November 2009. Permission to collect the coral used in this
study was issued by Autoridad Nacional del Ambiente (ANAM,
Government of Panama, permit #: SC/A-30-09). The coral
specimen was identified as Pseudopterogorgia acerosa
(Pallas) based on its morphology and SEM-micrographs of the
coral sclerites in the Smithsonian Tropical Research Institute. A
reference specimen was deposited at INDICASAT’s Center for
Anti-Inflammatory Activity of a Marine Diterpene
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Biodiversity and Drug Discovery (CBDD) under the number
GLBO-241109-03.
Isolation and characterization of compounds
The organism (958.8 g) was minced and exhaustively
extracted with CH2Cl2 and MeOH. The organic extract was
evaporated in vacuo to give 20.5 g of a dark oily residue. The
CHCl2-MeOH extract (20.0 g) was chromatographed by column
chromatography on silica gel and eluted with a stepwise
gradient of 0 %–100 % EtOAc in hexanes followed by 0 %–100
% MeOH in EtOAc to yield 10 fractions (A–J). Fraction H (1.0
g) was purified by a second column chromatography eluted
with a gradient of 6.3 %-70 % EtOAc in CH2Cl2 followed by 100
% acetone and 100 % methanol to yield 17 fractions (H1-H17).
Fraction H-7 yielded 35.2 mg of a pure pseudopterane
diterpene (1) [20]. Fraction F was concentrated (349 mg) and
further chromatographed on silica gel eluted with a stepwise
gradient of 50 %, 70 %, 100 % CH2Cl2 in hexanes, followed by
5 %, 10 %, 20 %, 30 %, 50 %, 70 %, 100 % of EtOAc in CH2Cl2
and 10 % MeOH in EtOAc to yield 21 fractions (F1-F21).
Fraction F19 was further purified by HPLC (5 µm Silica gel
Sphereclone column eluted with a gradient of 40 %–100 %
EtOAc in hexanes in 80 min at 1.0 mL/min) to yield 12 fractions
denoted I-XII. Fraction XI (13.3 mg) was re-injected in HPLC (5
µm Silica gel Sphereclone column eluted with a gradient of 75
%–100 % EtOAc in hexanes in 75 min at 1.0 mL/min) to yield 6
fractions (XIA-XI-F). Fraction XIE contained 1.1 mg of the
diterpene isogorgiacerodiol [21]. Structural determination of
both compounds was carried out by comparing their
spectroscopic data (1H-NMR, 13C-NMR and HRMS) and optical
rotations with those reported in the literature [20,21].
Macrophage culture
Peritoneal macrophages were obtained five days after i.p.
instillation of 2 mL of thioglycollate 3 %, by peritoneal washing
with chilled RPMI. Cells were seeded in RPMI with 10 % FCS
at 2x105/well in 96-well plates for cytokine determination,
2.5x106/well or 4x106/well in 6-well plates for western blot and
mRNA analysis respectively and cultured for 2 h at 37 °C in an
atmosphere of 5 % CO2. In all cases non-adherent cells were
removed by washing and adherent cells were stimulated as
indicated in figure legends. Briefly, for dose- response
experiments cells were treated with different concentrations of
compound 1 (2.5, 5, 12.5, 25 or 50 μM) 1 h previous to the
stimuli with 10 ng/mL of LPS, 100 ng/mL of Pam3Cys or
20µg/mL of Poly I:C. Supernatants were collected 24 h after
the stimulus and NO, TNF-α, IL-6, IL-1β or IP-10
concentrations were determined by ELISA. For western blot
Figure 1.  Schematic representation of compound 1.  
doi: 10.1371/journal.pone.0084107.g001
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and mRNA analyses cells were treated with 25 μM of
compound 1 and stimulated with LPS (100 ng/mL and 1 μg/mL,
respectively). Cell extracts were harvested at the time points
indicated in figure legends and run in SDS-PAGE for western
blot or used for RNA isolation for mRNA analysis.
Bone marrow derived macrophages (BMDM) were obtained
after differentiation of cells from murine femur and tibia. The
cells were cultured in a concentration of 4x106/10 mL in RPMI
containing 20 % FCS and 30 % L929 cell culture supernatant
at 37 °C in an atmosphere of 5 % CO2. After 4 days fresh
medium was added and macrophages were collected at day 7.
Adherent cells (1x106/well) were plated in 12-well plates in
RPMI medium supplemented with 10 % FCS and maintained at
37 °C an atmosphere of 5 % CO2. Cells were stimulated with
LPS (1 μg/mL) in the presence or absence of compound 1 (25
μM) for 24 h and the expression of CD80 and CD86 was
evaluated by flow cytometry.
All negative controls and stimulus were performed in the
presence of 0.5 % DMSO since compound 1 is solubilized in
DMSO. The known inhibitor of iNOS, the L-N6-(1-lminoethyl)
lysine dihydrochloride (L-N6), was used as an inhibition control
to test the cell-based assay.
Cytokine measurements
Peritoneal macrophages were cultured as previously
described. The concentrations of TNF-α, IL-6, IL-1β and IP-10
were determined by ELISA (DuoSet kit, R&D System, Inc.
Minneapolis, MN), according to the manufacturer’s protocol.
NO measurements
The accumulation of nitrite in cell supernatants was
measured as an indicator of NO production based on a Griess
assay. The concentration of nitrite was determined by the
Griess Reagent System (Promega, Madison, WI) according to
the manufacturer’s protocol.
Flow cytometry
The cells were harvested after 24 h of the stimulus, washed
with phosphate-buffered saline (PBS), and blocked with 200 µL
1 % BSA in PBS for 15 min. The cells were washed and then
incubated with (5 μg/mL) of anti-mouse CD11b FITC, anti-
mouse CD86 PE-Cy5 and/or anti-mouse CD80 APC
(eBioscience, SanDiego, CA) diluted in 1 % BSA in PBS, for 30
min at 4 °C. After several washes, the cells were resuspended
in PBS and analyzed by flow cytometry. Event acquisition was
performed with a Partec CyFlow® cytometer and the data were
analyzed using FlowMax software (PARTEC, Münster,
Germany) and FCS Express 4 Flow Cytometry (De Novo
software, Los Angeles, CA).
Quantitative Real Time RT-PCR
Total RNA from elicited peritoneal macrophages was
extracted using TRIzol (Life Technology Corporation: Invitrogen
and Applied Biosystems, Carlsbad, CA), and 2 µg were
reverse-transcribed using a High-Capacity cDNA reverse
transcription kit (Life Technology Corporation: Invitrogen and
Applied Biosystems, Carlsbad, CA). Subsequent quantitative
real time PCR analysis was performed on an ABI 7500
(Applied Biosystems) using SYBR Green master mix (Applied
Biosystems). Amplification conditions were as follows: 95 °C
(10 min), 40 cycles of 95 °C (15 s), and 60 °C (60 s). All data
were normalized to the corresponding HPRT expression, and
the difference relative to the control level was shown. Analyses
of relative gene expression data were performed by the 2-∆∆CT
method. The primers sequences are TNF forward 5’-
GGTCCCCAAAGGGATGAGAAGTTC- 3’ and reverse 5’-
CCACTTGGTGGTTTACTACGACG- 3’; IL-6 forward 5’-
TCATATCTTCAACCAAGAGGTA-3’ and reverse 5’-
CAGTGAGGAATGTCCACAAACTG-3’; IL-1β forward 5’-
GTAATGAAAGACGGCACA CC-3’ and reverse 5’-
ATTAGAAACAGTCCAGCCCA-3’; HPRT forward 5’-
GCTGGTGAAAAGGACCTCT- 3’ and reverse 5’-
CACAGGACTAGAACACCTGC- 3’; IP-10 forward 5’-
GAAATCCATCCCTGCGAGCCT-3’ and reverse 5’-
TTGATGGTCTTAGATTCCGGATTC -3’; iNOS forward 5’-
CCTCCACCCTACCAAGT-3’ and reverse 5’-
CAGCTCCAAGGAAGAGTGA-3’; COX-2 forward 5’-
CGTGGTCACTTTACTACGAG-3’ and reverse 5’-
AGGTACATAGTAGTCCTGAGC-3’; MCP-1 forward 5’-
CAGCAGGTGTCCCAAAGAAG-3’ and reverse 5’-
GACCTTAGGGCAGATGCAGT-3’.
Western blot analysis
Elicited peritoneal macrophages (2.5x106 cells/well) were
plated in 6-well plates. Non-adherent cells were removed after
2 h and adherent cells were stimulated as indicated in the
figure legends. Cells were lysed in a buffer consisting of Tris-
HCl (50 mM), NaCl (150 mM), NP40 (1 %), sodium
deoxycholate (0.25 %), EDTA (1 mM), aprotinin (5 μg/mL),
leupeptin (5 μg/mL), pepstatin (5 μg/mL), PMSF (1 mM),
sodium orthovanadate (1 mM) and NaF (1 mM), pH 7.5.
Twenty micrograms of protein diluted in loading buffer were
boiled and subjected to electrophoresis in SDS-polyacrilamide
gel (12 %) under reducing conditions. The proteins were
transferred to a PVDF membrane at 4 °C for 2 hours.
Membranes were then blocked with Tris-buffered saline
solution with 0.05 % of Tween-20 (TBS-T) and 5 % fat free milk
or TBS-T with 3 % of BSA for p-JNK detection. The
membranes were incubated overnight with anti-phospho (p)-
ERK1/2 (1/1000), anti-p-p38 (1/1000) (Cell Signaling
Technology, Inc. Boston, MA) or 48 h with anti-p-JNK (1/1000)
(Santa Cruz Biotechnology, Inc. Santa Cruz, CA) diluted in the
blocking solution. The membranes were washed in TBS-T and
incubated for 2 h with horseradish peroxidase-conjugated goat
anti-rabbit (1/10000) or goat anti-mouse (1/10000) IgG
polyclonal antibodies (Santa Cruz Biotechnology, Inc. Santa
Cruz, CA). Specific bands were detected by
chemiluminescence, using ECL substrate (Santa Cruz
Biotechnology, Inc. Santa Cruz, CA). The normalization was
performed by stripping membranes during 30 min at 50 °C in
stripping buffer (β-mercaptoethanol 100 mM, SDS 2 %, Tris-
HCl 62.5 mM, pH 6.7). After stripping, membranes were
washed with TBS-T, blocked with 5 % fat free milk TBS-T,
incubated overnight with rabbit anti-ERK2 (1/1000) (Santa Cruz
Biotechnology, Inc. Santa Cruz, CA) and detection was
Anti-Inflammatory Activity of a Marine Diterpene
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performed as described above. The degradation and
phosphorylation of IκBα protein was analyzed by western blot
with polyclonal rabbit anti-IκBα (Sigma Aldrich, St. Louis MO)
or monoclonal mouse phospho-IκBα (Ser32/36) (Cell Signaling
Technology, Inc. Boston, MA) diluted (1/1000) in blocking
solution. Detection of β-actin was used as loading control.
NFκB activation
The NFκB activation was determined using the Transcription
Factor Assay Kit, Trans AMTM NFκB family (Active Motif,
Carlsbad, CA). Cells (3x106/well) were stimulated with LPS in
the presence or absence of compound 1, at different time
intervals as described in the figure legends. The preparation of
nuclear extracts and measurement of NFκB activation was
performed as recommended by the manufacturer.
MTT assay
After the removal of supernatants, 100 µl of MTT (Sigma
Aldrich) (0.5 mg/mL) dissolved in RPMI was added to each well
and cells were incubated ON at 37 °C. The supernatants were
removed and formazan crystals were dissolved in 100 µl of
0.04 M HCl in isopropanol. The color was analyzed at 570 nm
using an ELISA plate reader. The percent of viable cells was
calculated using the formula: % viability: [(OD sample) x 100
%]/ (OD control). The non-stimulated cells and cultured in
medium plus 10 % FCS and 0.5 % DMSO represented 100 %
viability.
Statistical Analysis
Data are presented as means ± S.E.M. Results were
analyzed using a statistical software package (GraphPad Prism
5). Statistical analyses were performed by Student’s t test or
one-way ANOVAs followed by post hoc Tukey test. A
difference between groups was considered to be significant if P
< 0.05 (*, P < 0.05; **, P < 0.01). Inhibitory concentration 50 %
(IC50) values were calculated adjusting a sigmoidal dose-
response curve following GraphPad Prism 5 procedure.
Results
Compound 1 inhibits the production of TNF-α and IL-6
induced by LPS in murine peritoneal macrophages
LPS is a component of the outer membrane of Gram-
negative bacteria and is the most studied TLR4 ligand.
Signaling induced by LPS through TLR4 leads to the activation
of NFκB and the production of inflammatory mediators. In order
to evaluate the anti-inflammatory activity of compound 1, we
analyzed its ability to modulate the secretion of TNF-α and IL-6
pro-inflammatory cytokines by macrophages cultured with LPS.
Primary cultures of macrophages were treated with compound
1, which was either removed from the culture after one hour or
not, and then stimulated with LPS (Figure 2, A and B). We
observed that compound 1 suppressed the cytokine production
induced by LPS in macrophages even when it was removed
from the culture medium before the LPS treatment (Figure 2A),
indicating that it is not acting by sequestering the LPS out of
the supernatant.
We also performed a kinetic experiment by adding
compound 1 at different periods before and after LPS addition.
A significant inhibition of TNF-α and IL-6 secretion was
observed when the compound was added 1 h and 4 h after
LPS-treatment, respectively, suggesting that its inhibitory effect
may involve mechanisms associated to signaling steps
downstream from LPS recognition by TLR4 (Figure 2C).
Compound 1 inhibits the production of several pro-
inflammatory mediators induced by LPS at protein and mRNA
levels
We analyzed whether compound 1 would also inhibit the
production of other inflammatory mediators and the associated
dose response. Macrophages were treated with different doses
of compound 1 and stimulated with LPS. Treatment with
compound 1 inhibited the production of NO, TNF-α, IL-6, IL-1β
and IP-10 induced by LPS, in a concentration dependent
manner (Figure 3, A, B, C, D, E), with an IC50 ranging from 2.75
± 0.68 μM to 12.25 ± 0.40 μM (Table 1; Figure S2). The
inhibitory effect of compound 1 was not due to its cytotoxicity,
since concentrations between 12.5 μM and 25 μM did not
significantly interfere with cell viability, as determined by the
MTT method (Figure 3F and S3).
Analysis of mRNA levels in the cells treated with compound
1 and stimulated with LPS demonstrated a reduced induction of
TNF-α (3x), IL-6 (2x), IP-10 (2x) and IL-1β (2x), indicating that
compound 1 regulates the expression of these mediators at
transcriptional levels (Figure 4, A, B, C, D). Despite the fact
that the inhibition of IL-6 and IL-1β mRNA expression was not
statistically significant, we clearly detected a conserved trend in
several experiments, suggesting that the lack of statistical
significance might be the result of low power due to our small
sample size. We also measured the mRNA expression of
iNOS, which is responsible for NO production in LPS-
stimulated macrophages and found that iNOS mRNA levels
were much lower in cells treated with compound 1 in
comparison with the cells only stimulated with LPS (from 300 to
15 fold induction in non-treated and treated cells with
compound 1 respectively). This suggests that the inhibitory
effect on NO production may be associated with the regulation
of iNOS gene transcription (Figure 4E). Finally, LPS-stimulated
cells pretreated with compound 1 also showed decreased
mRNA levels of COX2 (25x) and MCP-1 (4x) (Figure 4, F and
G).
As isogorgiacerodiol (Figure S1) was isolated from the same
coral preparation as compound 1, we also analyzed its effect
on LPS-induced macrophage activation. Isogorgiacerodiol did
not affect the production of TNF-α induced by LPS in
macrophages, but inhibited NO production by these cells
(IC50=15.86 ± 2.58 μM for isogorgiacerodiol versus 7.54 ± 2.82
μM for compound 1; p =0.045). The IC50 values for IL-6
inhibition (12.25 ± 0.40 μM for compound 1 versus 21.56 ± 9.70
μM for isogorgiacerodiol) were not statistically different (p =
0.1105) (Figure S4). Taken together these results suggest that
compound 1 has a higher inhibitory effect than
isogorgiacerodiol.
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The Compound 1 Interferes with the Activation of NFκB
but Not of MAPKs Induced by LPS
It has been previously shown that compounds from the
diterpenes family have anti-inflammatory properties due to their
capacity to inhibit the activation of NFκB at different levels [4].
Therefore, we investigated the effect of compound 1 in the
NFκB activation pathway. Macrophages were treated with
compound 1 and stimulated with LPS. The activation of NFκB
(specifically the subunits p50 and p65) in nuclear extracts was
evaluated by ELISA. LPS induced the activation of p50 and
p65 after 30 min of stimulation, and this activation was
significantly reduced by compound 1 (Figure 5A).
Activation of NFκB requires its release from the IκBα inhibitor
after phosphorylation of IκBα by the IKK complex, thereby
inducing IκBα degradation. The degradation of IκBα was
analyzed by western blot, and we observed that the treatment
of macrophages with compound 1 prevented the IκBα
degradation induced by LPS stimulation for 15 and 30 min
(Figure 5B). On the other hand, we could not detect any
difference in the levels of phosphorylated IκBα (Figure 5C),
suggesting that the inhibitory effect of compound 1 is not
associated with the activation of the IKK complex.
Phosphorylation and activation of MAP kinases (MAPKs) is
another event triggered by activation of macrophages by LPS,
and it is essential for the production of inflammatory mediators
[22]. Diterpenoids isolated from natural sources have been
previously shown to inhibit the activation of MAPKs induced by
LPS [23]. Therefore, we evaluated whether compound 1 would
affect the phosphorylation of p-38, ERK 1/2, and JNK MAPK in
LPS-stimulated macrophages. We did not observe any
difference in MAPK phosphorylation in the cells treated or
untreated with the compound, indicating that these pathways
are not involved in the anti-inflammatory effect of compound 1.
Figure 2.  Compound 1 does not appear to interfere with LPS-TLR4 interaction.  (A, B) Peritoneal macrophages were treated
with 25 μM of compound 1. After 1 hour, compound 1 was either removed (A) or not (B) from the supernatant and cells were
stimulated with LPS (10 ng/mL). (C) Macrophages were treated with compound 1 (25 μM) 1 h before, at the same time, 1 h after or
4 h after LPS (10 ng/mL) stimulation. Supernatants were collected 6 h after the stimulus with LPS and TNF-α (black bars) and IL-6
(gray bars) concentrations were determined by ELISA. Results represent means ± S.E.M. from stimuli performed in duplicates and
are representative of two different experiments. *, P ˂ 0.05; **, P ˂ 0.01, compared with LPS stimulus alone.
doi: 10.1371/journal.pone.0084107.g002
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Compound 1 inhibits the activation of macrophages by
other TLRs ligands and TNF-α
Activation of NF-κB is a converging step in intracellular
signaling pathways elicited by different stimuli, including the
engagement of all TLRs and of cytokine receptors such as
TNFR. Therefore, we examined whether the inhibitory effect of
compound 1 would be expanded by other stimuli involved in
macrophage activation. Peritoneal macrophages were
stimulated by either TLR2 or TLR3 ligands (Pam3Cys and Poly
I:C, respectively) in the presence or absence of compound 1
and the production of different inflammatory mediators was
evaluated. Compound 1 inhibited, in a dose dependent
manner, the production of TNF-α and IL-6 induced by Pam3Cys
(Figure 6, A and B), with an IC50 of 5.28 ± 0.87 μM and 8.04 ±
0.25 μM, respectively (Table 1; Figure S5). The inhibitory effect
of compound 1 was also observed on the secretion of TNF-α,
IL-6 and IP-10 induced by Poly I:C (Figure 6, C, D, E), with IC50
values of 1.46 ±.0.11μM, 3.26 ± 0.94 μM and 7.10 ± 0.97 μM
respectively (Table 1; Figure S5). These effects were not due
to the cytotoxicity of the compound since at inhibitory
concentrations cells were still viable (Figure 6, F and G).
TNF-α is produced by macrophages in many pathological
conditions and has an autocrine and paracrine effect through
its recognition by the TNF receptors (TNFR). TNFR
engagement induces the recruitment of adaptor proteins,
leading to activation of IKK and NFκB, which then stimulate the
transcription of inflammatory genes. Since we observed that
macrophage treatment with compound 1 decreased the mRNA
levels of inflammatory mediators induced by LPS, we evaluated
whether it would have the same effect on macrophage
stimulation by TNF-α. Peritoneal macrophages were stimulated
with TNF-α in the presence or absence of compound 1 and the
Table 1. Compound 1 IC50 values for each inflammatory
mediator.
 IC50 ± S.D. (μM)
Mediator LPS Pam3Cys Poly I:C
NO 7.54 ± 2.82 n.a. n.a.
TNF 9.16 ± 0.83 5.28 ± 0.87 1.46 ± 0.11
IL-6 12.25 ± 0.40 8.04 ± 0.25 3.26 ± 0.94
IL-1β 2.75 ± 0.68 n.a. n.a.
IP-10 3.73 ± 0.57 n.a. 7.10 ± 0.97
Values represent average of IC50 from three independent experiments ± S.D.
IC50 (positive control) = 1.47 ± 0.83 μM (value corresponds to the inhibition of NO
production by the iNOS inhibitor L-N6).
n.a., not analyzed.
doi: 10.1371/journal.pone.0084107.t001
Figure 3.  Compound 1 inhibits the production of pro-inflammatory mediators induced by LPS in macrophages.  Peritoneal
macrophages were treated with the indicated concentrations of compound 1 (2.5, 5, 12.5, 25 or 50 μM). After 1 hour cells were
stimulated with 1 μg/mL (A) or 10 ng/mL (B-F) of LPS. Supernatants were collected 24 h after the stimulus and NO (A), TNF-α (B),
IL-6 (C), IL-1β (D) and IP-10 (E) concentrations were determined. (F) Cell viabilities were assessed using a MTT assay after
supernatant collection. Results represent means ± S.E.M. from stimuli performed in duplicates and are representative of three
different experiments. *, P ˂ 0.05; **, P ˂ 0.01, compared with LPS stimulus alone. (F) *, P<0.05 compared with the control without
stimulus.
doi: 10.1371/journal.pone.0084107.g003
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levels of mRNA were determined by quantitative real time
PCR. We observed that stimulation of macrophages with TNF-
α induced the expression of TNF-α, IL-1β, IP-10 and MCP-1
mRNA (6, 4, 8 and 4 mRNA fold induction respectively), which
were all abrogated when the cells were pretreated with
compound 1 (Figure 7).
The expression of CD80 and CD86 induced by LPS is
reduced by the treatment with compound 1
Activation of macrophages is also associated with several
phenotypic changes, including the expression of the activation
markers CD80 and CD86, which are essential for their co-
stimulatory activity over adaptive immunity [24]. Thus, we
assessed if compound 1 would have an effect on LPS-induced
CD80 and CD86. Bone marrow derived macrophages were
stimulated with LPS in the presence or absence of compound 1
and the expression of CD80 and CD86 was evaluated by flow
cytometry. Macrophages treated with LPS showed a marked
increase in the expression of CD80 and CD86 in comparison to
non-stimulated cells (Figure 8). Interestingly, addition of
compound 1 to the cultures strongly reduced the expression of
both molecules, as measured by the decreased mean
fluorescence intensities detected in the cells treated with LPS
and compound 1 (Figure 8). These results indicate that
compound 1 may modulate a variety of processes occurring
during macrophage activation.
Figure 4.  Expression of pro-inflammatory genes induced by LPS is inhibited by Compound 1.  Peritoneal macrophages were
treated with compound 1 (25 μM) and stimulated with LPS (1 μg/mL). After 180 min the RNA was isolated following the Trizol
method. The amount of mRNA for TNF-α (A), IL-6 (B), IP-10 (C), IL-1β (D), iNOS (E), COX-2 (F) and MCP-1 (G) was determined by
real-time RT-PCR. Results were normalized to HPRT expression and are presented as fold induction of mRNA expression relative
to control samples. Results represent means ± S.E.M. from stimuli performed in duplicates and are representative of two different
experiments. *, P ˂ 0.05; **, P ˂ 0.01, compared with LPS stimulus alone.
doi: 10.1371/journal.pone.0084107.g004
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Discussion
In the present work we identified compound 1, a diterpenoid
isolated from the coral P. acerosa, as a potential anti-
inflammatory molecule. Compound 1 inhibited the production of
pro-inflammatory mediators induced by different TLRs ligands
and TNF-α in macrophages. Our data suggest that this
inhibitory effect was due to blocking of IκBα protein degradation
and subsequent activation of the NFκB.
Diterpenes are secondary metabolites that can be found in
higher plants, fungi, insects and marine organisms and have
the largest range of biological activities among the terpenoid
family [4]. The anti-inflammatory characteristics of some
members of diterpenoid family, especially those isolated from
plants, have been described and mostly involve the inhibition of
the NFκB signaling pathway at different levels [4]. Compound 1
was previously characterized as a methanol adduct of the
diterpenoid pseudopterolide [20] and later isolated as a natural
product [21], but its effect on inflammatory response had not
been addressed previously.
We first evaluated the anti-inflammatory activity of compound
1 in macrophages’ response to LPS, which is a well
characterized ligand of TLR4. The recognition of LPS by TLR4
leads to the recruitment of the adaptor proteins MyD88
(Myeloid differentiation primary response gene 88) and TRIF
(TIR-domain-containing adapter-inducing interferon-β). The
Figure 5.  NF-κB activation induced by LPS is inhibited by compound 1.  (A) Macrophages were treated or not with compound
1 (25 μM) and stimulated with LPS (100 ng/mL). After the indicated times nuclear extracts were prepared and the activation of p50
and p65 was evaluated using a TransAM assay. Results represent means ± S.E.M. from stimuli performed in duplicates and are
representative of two different experiments. **, P ˂ 0.01, compared with LPS stimulus alone. Macrophages were treated as above
and cell extracts were run in SDS-PAGE. IκBα degradation (B) and phosphorylation (C) was detected by immunoblotting. Detection
of β-actin was used as loading control. The figures are representative of two different experiments with similar results. (D)
Macrophages were stimulated for 30 min with LPS (100 ng/mL) in the presence or absence of compound 1 (25 μM). Cell extracts
were submitted to SDS-PAGE. ERK1/2, JNK, and p38 phosphorylation was detected by immunoblotting. Detection of
nonphosphorylated ERK2 was used as loading control. The figures are representative of two different experiments with similar
results.
doi: 10.1371/journal.pone.0084107.g005
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signal through MyD88 leads to the activation of NFκB and
MAPKs, inducing the production of inflammatory cytokines,
whereas the signal through TRIF induces the activation of
IRF3, the induction of type I interferon and the late activation of
NFκB [22]. All TLRs except TLR3 recruit MyD88, and TRIF is
recruited by TLR3 and TLR4 [22]. The activation of NFκB
through MyD88 and TRIF pathways depends on the
degradation of IκBα after its phosphorylation by the IKK
complex [7]. The gene transcripts induced after NFκB
activation include pro-inflammatory mediators such as iNOS,
COX-2, TNF-α, IL-1β, IL-6, MCP-1, and IP-10 among others
[25].
We demonstrated that compound 1 inhibited, in a dose
dependent manner, the production of inflammatory mediators
such as NO, TNF-α, IL-6, IL-1β and IP-10 induced by LPS in
macrophages. Moreover, compound 1 seems to have a higher
inhibitory effect than isogorgiacerodiol, a known P. acerosa
metabolite with very similar structure to compound 1 [21].
Compound 1 structurally differs from isogorgiacerodiol only by
the presence of a methoxy group at C-9 (compound 1) instead
of the hydroxy group at same carbon (isogorgiacerodiol),
suggesting that this functional group may be essential for the
greater effectiveness of compound 1. Previous reports support
this possibility because it has been shown that subtle structural
differences in small molecules are essential for modifying their
immune modulation activities [26]. However, further studies are
necessary to elucidate the molecular bases of the observed
differences.
Analysis of mRNA levels corresponding to inflammatory
mediators demonstrated that compound 1 inhibited the LPS-
induced transcription of TNF-α, IL-6, IL-1β, IP-10, MCP-1, and
iNOS. Given that most of the non-steroidal anti-inflammatory
Figure 6.  The production of pro-inflammatory mediators induced by other TLRs ligands is inhibited by Compound
1.  Peritoneal macrophages were treated with the indicated concentrations of compound 1 (2.5, 5, 12.5, 25 or 50 μM). After 1 hour
cells were stimulated with 100 ng/mL of Pam3Cys (A, B, F) or 20 μg/mL of Poly I:C (C-E, G). Supernatants were collected 24 h after
the stimulus and TNF-α (A, C), IL-6 (B, D) and IP-10 (E) concentrations were determined. (F, G) Cell viabilities were assessed using
a MTT assay after supernatant collection. Results represent means ± S.E.M. from stimuli performed in duplicates and are
representative of three different experiments. *, P ˂ 0.05; **, P ˂ 0.01, compared with LPS stimulus alone.
doi: 10.1371/journal.pone.0084107.g006
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drugs (NSAID) are inhibitors of COX2, we also analyzed COX2
mRNA levels. Interestingly, a significant reduction in the
concentration of COX2 mRNA was observed, demonstrating
that compound 1 has a broad effect on the transcription of pro-
inflammatory genes associated with the LPS response.
The inhibitory effect of compound 1 did not occur by
competition with LPS for interaction with TLR4, since the
inflammatory stimulus was inhibited even when compound 1
was added to the cultures after the addition of LPS. These
results also suggest that compound 1 crosses the plasma
membrane and achieves its effect by interacting with
cytoplasmic signaling molecules. Diterpenoids from different
families have hydrophobic characteristics that were previously
associated with their ability to be incorporated in membranes
[27-29]. Therefore, the nonpolar characteristics of compound 1
could also facilitate it crossing the plasmatic membrane.
Several reports have demonstrated that diterpenoids from
different natural sources act as inhibitors of the NFκB signaling
pathway [30-32]. A Briarane, a diterpenoid isolated from the
gorgonian octocoral Briareum excavatum, inhibited the
cutaneous inflammation induced by TPA by interfering with the
NFκB pathway [15]. Also, bharangin, a diterpenoid isolated
from the medicinal plant Premna herbacea, inhibited the
activation of NFκB by modifying residues on the p65 subunit
and inhibiting the activation of IκBα [33]. Since NFκB regulates
the expression of the pro-inflammatory mediators TNF-α, IL-6,
IL-1β, IP-10, iNOS, COX2 and MCP-1 [25], we evaluated
whether the anti-inflammatory effect of compound 1 would be
attributed to inhibition of the NFκB signaling pathway. We
demonstrated that compound 1 prevented the activation of the
p50 and p65 subunits and the degradation of IκBα in LPS-
stimulated macrophages. However, the phosphorylation of IκBα
Figure 7.  Compound 1 inhibits the expression of genes induced by TNF-α.  Peritoneal macrophages were treated with
compound 1 (25 μM) and stimulated with TNF-α (100 ng/mL). As a control, the cells were cultured with DMSO diluent. After 240 min
of stimuli RNA was isolated following the Trizol method. The concentration of mRNA for TNF-α (A), IL-1β (B), IP-10 (C) and MCP-1
(D) was determined by real-time RT-PCR. Results were normalized to HPRT expression and are presented as fold induction of
mRNA expression relative to control samples. Results represent means ± S.E.M. from stimuli performed in duplicates and are
representative of two different experiments. *, P ˂ 0.05; **, P ˂ 0.01, compared with TNF-α stimulus alone.
doi: 10.1371/journal.pone.0084107.g007
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in response to LPS was not affected by compound 1,
suggesting that upstream components of the NFκB pathway
are not affected. Compound 1 might be interfering with the
ubiquitin - proteasome pathway, leading to the accumulation of
p-IκBα. Inhibition of proteasome activity by terpenoids had
been previously described and was associated with anti-
inflammatory and/or anti-cancer functions [34,35]. Therefore,
the role of compound 1 in the inhibition of ubiquitin -
proteosome pathway needs to be investigated further.
MAPKs are regulatory proteins involved in different signaling
pathways triggered by activation of several innate immune
receptors, such as TLR4. Four MAPKs cascades have been
identified, including ERK1/2, JNK and p38 MAPK, and the
activation of these cascades stimulated by TLR ligands in
macrophages is involved in the induction of pro-inflammatory
genes [22,36]. We did not observe any effect of compound 1
on the activation of ERK1/2, p38 and JNK induced by LPS in
macrophages. Previous reports analyzing the effect of a marine
diterpenoid of the briarane family in an in vivo model of TPA-
induced dermatitis also demonstrated a selective inhibitory
effect on NFκB activation with no interference with ERK1/2
activation [15].
Figure 8.  Compound 1 inhibits the expression of CD80 and CD86 induced by LPS in macrophages.  Bone marrow derived
macrophages were stimulated with LPS (1 μg/mL) in the presence or absence of compound 1 (25 μM). After 24 h cells were
collected for FACS analysis of CD11b, CD80 and CD86 expression. Representative histograms of CD80 (A) and CD86 (B) on
CD11b+ cells are shown from three different experiments. Graphics from CD80 (C) and CD86 (D) for the mean of fluorescence
intensity on CD11b+ gated cells. Results represent means ± S.E.M. from two independent experiments. *, P ˂ 0.05, compared with
LPS stimulus alone.
doi: 10.1371/journal.pone.0084107.g008
Anti-Inflammatory Activity of a Marine Diterpene
PLOS ONE | www.plosone.org 12 December 2013 | Volume 8 | Issue 12 | e84107
Stimulation of an inflammatory response by macrophages
can also be induced by other TLR ligands and by the
engagement of cytokine receptors, such as TNFR. The cellular
activation elicited by these receptors requires different adaptor
molecules and triggers several initial signaling pathways, but
most of them culminate in the activation of NFκB through the
phosphorylation and degradation of IκBα [22,37,38]. We
observed that compound 1 inhibited the production of pro-
inflammatory mediators induced by TNF-α and by TLR2
(Pam3Cys) and TLR3 (Poly I:C) ligands, which are
representative of the activation of MyD88-dependent and
independent pathways, respectively. Further studies should be
conducted to define whether this effect was also related to
modulation of NFκB activation or was associated with upstream
signals triggered by TNFR1 and TLR engagement.
TLR2 is involved in the recognition of molecules derived from
different pathogens such as bacteria, fungi, parasites and
viruses. The production of inflammatory mediators induced by
the activation of TLR2 depends on the recruitment of TIRAP
and MyD88 adaptor molecules. TLR3 is essential in the
recognition of virus dsRNA and specific small interfering RNA.
Activation of TLR3 promotes the production of type I interferon
and pro-inflammatory cytokines through the recruitment of the
adaptor TRIF. Previous studies have shown the anti-
inflammatory effect of various diterpenoids on the inhibition of
the NFκB pathway triggered by TLR2 ligands [39]. The effect of
the diterpenoid triptolide in the inhibition of the expression of
genes induced by Poly I:C in macrophages has also been
shown [40].
The activation of macrophages through PRR receptors
induces the expression of major histocompatibility complex
(MHC) and co-estimulatory molecules such as CD40, CD80
and CD86, which are critical for T cell activation [41]. Natural
compounds have been described as modulators of the
macrophage phenotype, which in turn affects the adaptive
immune response [42,43]. We observed that compound 1
inhibited the expression of activation markers such as CD80
and CD86 induced by LPS in macrophages, suggesting that it
may also interfere with the subsequent initiation of an adaptive
immune response.
In this work we demonstrated a previously unknown
biological effect of the pseudopterane compound 1. This
molecule presented a relevant anti-inflammatory activity
evidenced by a decrease in the expression and production of
the pro-inflammatory mediators TNF-α, IL-6, IL-1β, IP-10,
iNOS, COX2 and MCP-1 induced by LPS in macrophages
without affecting cell viability. This activity was associated with
its capacity to inhibit the degradation of IκBα and the
subsequent activation of NFκB after LPS treatment. Compound
1 inhibited not only the response of macrophages to LPS, but
also the response to TNF-α and ligands of TLR2 and TLR3.
This compound also inhibited the expression of the co-
stimulatory molecules CD80 and CD86 in response to LPS.
Taken together, our results suggest that compound 1 might be
a potential therapeutic agent for a variety of infectious and
inflammatory diseases.
Supporting Information
Figure S1.  Schematic representation of isogorgiacerodiol.
(TIF)
Figure S2.  Compound 1 inhibits the production of
inflammatory mediators induced by LPS in murine
macrophages. IC50 sigmoidal curves calculated by the
statistical software package GraphPad Prism 5 from the
representative experiments shown in Figure 3. Graphs
represent the sigmoidal curves for the IC50 calculation of NO
(A), TNF-α (B), IL-6 (C), IL-1β (D) and IP-10 (E) induced by
LPS in the presence of compound 1. Results represent means
± S.D. from stimuli performed in duplicates.
(TIF)
Figure S3.  Compound 1 is not cytotoxic for macrophages.
Peritoneal macrophages from C57Bl/6 mice were treated with
different concentrations of compound 1 (2.5, 5, 12.5, 25, 50
μM). After 24 h supernatants were collected and cell viabilities
were assessed by a MTT assay. Results represent means ±
S.E.M. from stimuli performed in duplicates.
(TIF)
Figure S4.  Isogorgiacerodiol inhibits the production of
pro-inflammatory mediators induced by LPS in
macrophages. Peritoneal macrophages were treated with the
indicated concentrations of isogorgiacerodiol (2.5, 5, 12.5, 25
or 50 μM). After 1 hour cells were stimulated with 10 ng/mL (A,
B) or 1 μg/mL (C) of LPS. Supernatants were collected 24
hours after the stimulus and TNF-α (A), IL-6 (B) and NO (C)
concentrations were determined. Results represent means ±
S.E.M. from stimuli performed in duplicates and are
representative of three different experiments. *, P ˂ 0.05; **, P
˂ 0.01, compared with LPS stimulus alone.
(TIF)
Figure S5.  Compound 1 inhibits the production of
inflammatory mediators induced by Pam3Cys and Poly I:C
in murine macrophages. IC50 sigmoidal curves calculated by
the statistical software package GraphPad Prism 5 from the
representative experiments shown in Figure 6. (A, B) Sigmoidal
curves for TNF-α and IL-6 induced by Pam3Cys in the presence
of compound 1. (C-E) Sigmoidal curves for TNF-α, IL-6 and
IP-10 induced by Poly I:C in the presence of compound 1.
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